Adriana Feder

Data updated March 24, 2026

Papers

5 publications

Trials

0 clinical trials

Links

Research Footprint

Adriana Feder appears in 5 tracked papers (2014–2022), most studied alongside Ketamine and Placebo, across Depressive Disorders, PTSD and Bipolar Disorder.

Most-cited paper: The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis (672 citations).

Frequent co-authors: James Murrough, Dennis Charney and Manohar Jha.

5

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

18 collaborators· click a node to visit their profile

Full network →

Compounds

Ketamine Placebo

Topics

Depressive Disorders PTSD Bipolar Disorder Safety & Risk Management Treatment-Resistant Depression (TRD)Neuroimaging & Brain Measures Suicidality Public Health, Prevention & Behaviour Change

Top Collaborators

Affiliations

Institutions, companies, and organisations Adriana Feder is associated with.

Icahn School of Medicine at Mount Sinai

Icahn School of Medicine at Mount Sinai is a leading US academic medical institution home to the Parsons Research Center for Psychedelic Healing, which runs rigorous clinical trials of MDMA- and psilocybin-assisted therapies for PTSD and trauma in veteran and civilian populations.

View stakeholder →